NDA submitted for amprenavir.
D002219:Carbamates; D005663:Furans; D017320:HIV Protease Inhibitors / Q000627:therapeutic use*; D006801:Humans; D017387:Investigational New Drug Application; D013449:Sulfonamides / Q000627:therapeutic use*
D002219:Carbamates; D005663:Furans; D017320:HIV Protease Inhibitors; D013449:Sulfonamides; C095108:amprenavir